Liver Cancer Trial, Recruiting (NCT04075305)

Liver Cancer Trial, Recruiting NCT04075305 Sponsor: UMC Utrecht Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04075305 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled to have, or have already had, imaging or treatment on a machine called an MR-Linac (a combined MRI scanner and radiation therapy machine)
People who are willing and able to sign a written consent form agreeing to take part
People who are 18 years of age or older

Who may not be able to join:

People who are unable to have an MRI scan for medical reasons, including those who may be pregnant, those who experience severe anxiety in enclosed spaces (claustrophobia), or those who have metal or electronic devices in their body that are not safe to use near an MRI machine (confirm with trial site for a full list of MRI restrictions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Helena M Verkooijen, Prof, Dr, Universitair Medical Centre Utrecht

Phone: T +31 (0)88 75 63707

Australian sites

Austin Health - Olivia Newton-John Cancer Wellness and Research Centre, Melbourne,

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04075305

Sponsor: UMC Utrecht

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: T +31 (0)88 75 63707

More information: https://clinicaltrials.gov/study/NCT04075305

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled to have, or have already had, imaging or treatment on a machine called an MR-Linac (a combined MRI scanner and radiation therapy machine)
People who are willing and able to sign a written consent form agreeing to take part
People who are 18 years of age or older

Who may not be able to join:

People who are unable to have an MRI scan for medical reasons, including those who may be pregnant, those who experience severe anxiety in enclosed spaces (claustrophobia), or those who have metal or electronic devices in their body that are not safe to use near an MRI machine (confirm with trial site for a full list of MRI restrictions)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

UMC Utrecht

Registry

ClinicalTrials.gov

Start date

1 February 2019

Est. completion

1 February 2030

Where this trial is recruiting

🇦🇺 Australia 🇧🇪 Belgium 🇨🇦 Canada 🇩🇰 Denmark 🇩🇪 Germany 🇮🇹 Italy 🇳🇱 Netherlands 🇬🇧 United Kingdom 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Progression-free Survival; Progression-free Survival; Progression-free Survival; Survival; Survival; Survival; Disease-free Survival; Disease-free Survival; Disease-free Survival; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient reported Health related quality of life (HRQoL).; Patient report...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov